Literature DB >> 34033799

A user's guide to multicolor flow cytometry panels for comprehensive immune profiling.

Staffan Holmberg-Thyden1, Kirsten Grønbæk2, Anne Ortved Gang3, Daniel El Fassi3, Sine Reker Hadrup4.   

Abstract

Multicolor flow cytometry is an essential tool for studying the immune system in health and disease, allowing users to extract longitudinal multiparametric data from patient samples. The process is complicated by substantial variation in performance between each flow cytometry instrument, and analytical errors are therefore common. Here, we present an approach to overcome such limitations by applying a systematic workflow for pairing colors to markers optimized for the equipment intended to run the experiments. The workflow is exemplified by the design of four comprehensive flow cytometry panels for patients with hematological cancer. Methods for quality control, titration of antibodies, compensation, and staining of cells for obtaining optimal results are also addressed. Finally, to handle the large amounts of data generated by multicolor flow cytometry, unsupervised clustering techniques are used to identify significant subpopulations not detected by conventional sequential gating.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Flow cytometry; Immune monitoring; Immunology; Myelodysplastic syndrome; Unsupervised clustering

Year:  2021        PMID: 34033799     DOI: 10.1016/j.ab.2021.114210

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases.

Authors:  Cristina Faccani; Gianluca Rotta; Francesca Clemente; Maya Fedeli; Danilo Abbati; Francesco Manfredi; Alessia Potenza; Achille Anselmo; Federica Pedica; Guido Fiorentini; Chiara Villa; Maria P Protti; Claudio Doglioni; Luca Aldrighetti; Chiara Bonini; Giulia Casorati; Paolo Dellabona; Claudia de Lalla
Journal:  Life Sci Alliance       Date:  2022-06-03

Review 2.  Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead.

Authors:  Basak Aru; Mojdeh Soltani; Cemil Pehlivanoglu; Ege Gürlü; Mazdak Ganjalikhani-Hakemi; Gülderen Yanikkaya Demirel
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

Review 3.  CyTOF® for the Masses.

Authors:  Akshay Iyer; Anouk A J Hamers; Asha B Pillai
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.